Celebrating the 2024 Nobel Prize Winners in Chemistry and Physics
We are delighted to celebrate the announcement of the 2024 Nobel Prize winners in Chemistry and Physics, which include London’s UCL alumnus Sir Demis Hassabis for his work with AI company, Google DeepMind, and Professor Geoffrey E. Hinton who founded the Gatsby Computational Neuroscience Unit at UCL.
These incredible triumphs in computational science are reflective of the depth of talent and pioneering capabilities of London’s research community which ranks 2nd worldwide for AI talent and is home to over 357,000 developers. Following the tremendous recognition of the value of machine learning in life sciences, we are excited to highlight a few key companies to watch in London:
LabGenius
LabGenius uses machine learning to design and optimise therapeutic proteins through active learning to enable to co-optimisation of antibodies across multiple properties, and target intractable diseases and have raised £35m this year.
Relation Therapeutics
Relation Therapeutics tackles the drug discovery bottleneck of limited disease biology understanding, often leading to trial failures, by using machine learning to rationally discover new therapeutics. They have raised $35m this year.
Scarlet
Scarlet certifies Software Medical Devices and addresses regulatory gaps in rapidly evolving health software by providing a framework for scalable and continuous product development and monitoring, and has raised $17.5m this year.
Baseimmune
Utilises computational platform deciphering pathogen evolution to design cross-protective vaccines, and have raised £9m this year.
We look forward to following the success of these pioneering companies and witnessing the transformative impact they will have on the healthcare and biotechnology industries. Their innovative approaches and significant funding achievements position them to make substantial advancements in their respective fields, ultimately improving patient outcomes and addressing some of the most challenging medical issues of our time